ClinicalTrials.gg
Sign In

Shanghai Jeyou Pharmaceutical Co., Ltd. clinical trials

The registry lists 3 studies whose lead sponsor is Shanghai Jeyou Pharmaceutical Co., Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 24, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Shanghai Jeyou Pharmaceutical Co., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 4 programmes

Each counted once: 4 with a study Shanghai Jeyou Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 2 phase-3 programmes — sign in to see them, free: with every programme, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Shanghai Jeyou Pharmaceutical Co., Ltd.’s own registered studies; Shanghai Jeyou Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Shanghai Jeyou Pharmaceutical Co., Ltd.’s studies test, most open studies first — 2 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Shanghai Jeyou Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

The study

Add it to your calendar (.ics) → With an account.

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now3100%

Phase

  • Phase 11
  • Phase 31
  • Phase 21

Where

  • China3

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shanghai Jeyou Pharmaceutical Co., Ltd..

  • Shanghai Jeyou Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies

Studies

Recruiting first, then most recently updated. Showing 3 of 3.